Shares of Innospec Inc. (NASDAQ:IOSP) have been given a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy rating. Innospec’s rating score has improved by 50% from three months ago as a result of a number of analysts’ ratings changes.

Brokerages have set a 12 month consensus target price of $69.00 for the company and are anticipating that the company will post $0.85 earnings per share for the current quarter, according to Zacks. Zacks has also given Innospec an industry rank of 69 out of 265 based on the ratings given to its competitors.

IOSP has been the topic of a number of research analyst reports. Zacks Investment Research downgraded Innospec from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 12th. BidaskClub downgraded Innospec from a “sell” rating to a “strong sell” rating in a report on Thursday, July 27th. ValuEngine downgraded Innospec from a “buy” rating to a “hold” rating in a report on Monday, August 7th. Finally, Monness Crespi & Hardt raised Innospec from a “neutral” rating to a “buy” rating and set a $65.00 target price on the stock in a report on Tuesday, August 22nd.

A number of large investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. lifted its holdings in Innospec by 0.4% during the 3rd quarter. Principal Financial Group Inc. now owns 426,095 shares of the specialty chemicals company’s stock worth $26,269,000 after buying an additional 1,811 shares during the last quarter. Mondrian Investment Partners LTD lifted its holdings in Innospec by 22.2% during the 3rd quarter. Mondrian Investment Partners LTD now owns 82,307 shares of the specialty chemicals company’s stock worth $5,074,000 after buying an additional 14,942 shares during the last quarter. American Century Companies Inc. lifted its holdings in Innospec by 24.4% during the 3rd quarter. American Century Companies Inc. now owns 449,089 shares of the specialty chemicals company’s stock worth $27,686,000 after buying an additional 88,053 shares during the last quarter. Emerald Mutual Fund Advisers Trust lifted its holdings in Innospec by 5.2% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 162,972 shares of the specialty chemicals company’s stock worth $10,047,000 after buying an additional 8,010 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in Innospec by 33.4% during the 3rd quarter. Victory Capital Management Inc. now owns 3,629 shares of the specialty chemicals company’s stock worth $224,000 after buying an additional 909 shares during the last quarter. 89.12% of the stock is currently owned by institutional investors.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings results on Tuesday, August 8th. The specialty chemicals company reported $1.16 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.08. The firm had revenue of $326.30 million during the quarter. Innospec had a return on equity of 14.77% and a net margin of 7.22%.

TRADEMARK VIOLATION WARNING: “Innospec Inc. (IOSP) Given $69.00 Average Target Price by Brokerages” was posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/11/03/innospec-inc-iosp-given-69-00-average-target-price-by-brokerages.html.

About Innospec

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Get a free copy of the Zacks research report on Innospec (IOSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with MarketBeat.com's FREE daily email newsletter.